Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Advisory Committee Briefing Materials For Crestor sNDA Available On US FDA Web Site
-
US FDA Approves Seroquel For The Paediatric Treatment Of Schizophrenia And Bipolar Mania
-
US FDA Approves Seroquel XR For Add-On Treatment Of Major Depressive Disorder
-
AstraZeneca and Targacept Form Global Collaboration and Licence Agreement for Late-Stage Investigational Product TC-5214 for the Treatment of Major Depressive Disorder
-
AstraZeneca Submits US New Drug Application for Brilinta (Ticagrelor), an Investigational Antiplatelet Agent
-
Results from Two Phase II Trials Add to Understanding of Brilinta (Ticagrelor) and How it Works in the Body
-
BRILINTA Demonstrated Greater Efficacy Over Clopidogrel in the Most Urgent Clinical Setting: Patients with ST-Segment Elevation Myocardial Infarction and Planned Percutaneous Coronary Intervention (PCI)
-
Discovery Research Leader Leaves AstraZeneca
-
AstraZeneca PLC Third Quarter & Nine Months Results 2009
-
AstraZeneca withdraws regulatory submissions for Zactima (vandetanib) in combination with chemotherapy for advanced NSCLC
Latest articles and press releases
All of our latest press releases and articles are available to explore
